Transfusion-dependent anemia after initiation of androgen deprivation therapy for metastatic prostate cancer
In the Phase I/II KRYSTAL-1 study, Krazati plus cetuximab elicited a confirmed overall response rate of 34%, all of which were partial responses, meeting the primary endpoint, according to BMS
This state can lead to low-level, persistent inflammation, which is closely linked to weight gain and difficulty losing weight
It's also the best choice for anyone requiring iron supplementation, including those with compromised digestive systems and sensitive stomachs
Pineal Peptides (Epitalon, Endoluten) Circadian & Mitochondrial Support Restores melatonin levels, which protects against kidney fibrosis
, Integrative Peptides, BPC-157, 500